(Q51495683)

English

Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat.

scientific article published on 27 June 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

author name string

Hofman PL

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

Gluckman PD

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

Lobie PE

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

Cutfield WS

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

publication date

27 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

291

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

E1212-9

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Effect of growth hormone on carbohydrate and lipid metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Four decades of growth hormone therapy for short children: what have we achieved?

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Role of Growth Hormone in Fluid Homeostasis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Regulation of MDCK cell-substratum adhesion by RhoA and myosin light chain kinase after ATP depletion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

RhoA/ROCK activation by growth hormone abrogates p300/histone deacetylase 6 repression of Stat5-mediated transcription

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Fetal growth and adult diseases

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00614.2005

21 January 2018

Identifiers

10.1152/AJPENDO.00614.2005

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16803850

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51495683&oldid=812514231"